Skip to main content
TipRanks
Go Ultimate75% OFF

Hemab Therapeutics Holdings, Inc. (COAG) Cash flow

16 Followers

Hemab Therapeutics Holdings, Inc. Cash Flow

COAG's free cash flow for Q3 2026 was $-28.29M. For the 2026 fiscal year, COAG's free cash flow was decreased by $-34.00K and operating cash flow was $-28.29M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25
$ -61.48M
$ -81.48M
$ 156.30M
$ 87.97M
$ -61.49M

Currency in USD

Hemab Therapeutics Holdings, Inc. Cash Flow

-100M-50M050M100M150M200M2025OperatingInvestingFinancing